Labetalol Infusion and Dexmedetomidine Infusion in Hypotensive Anesthesia

ConditionsHypotensive Anesthesia Ear, Nose and Throat Procedure

Trial statusRecruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexAll

Age20-50

SponsorAin Shams University

About this trial

this study aims to compare between the role of Labetalol infusion versus Dexmedetomidine infusion in hypotensive anesthesia in Ear, Nose and Throat surgeries.

Eligibility criteria

Qualifiers

American Society of Anesthesiologists I, II (ASA I, II) patients who were candidate for Ear, Nose and Throat surgeries.

Age: between 20 and 50 years

Disqualifiers

Patients with uncontrolled hypertension, variable degrees of heart block, congestive cardiac failure, coagulopathy, cerebral insufficiency, hepatic or renal abnormality

Patients on beta blocker or clonidine

Pregnant or lactating females

Patients who were allergic to any of the anesthetic or hypotensive drugs used in the study

Trial design

Treatments tested in this trial

Hypotensive anesthesia in ear, nose and throat surgeries using labetalol and dexmedetomidine infusions

Treatment groups

80 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Ain Shams University

Lead sponsor

Source ClinicalTrials.gov